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ABSTRACT  Outline  of the  steps  in  protein  synthesis.  Nature  of  the  genetic
code.  The use of synthetic  oligo-  and polynucleotides  in deciphering  the  code.
Structure  of the  code:  relatedness  of synonym codons.  The wobble  hypothesis.
Chain  initiation  and  N-formyl-methionine.  Chain  termination  and  nonsense
codons.  Mistakes  in translation:  ambiguity  in vitro.  Suppressor  mutations  re-
sulting in ambiguity.  Limitations  in the universality  of the  code. Attempts  to
determine  the particular codons used by a  species.  Mechanisms  of suppression,
caused  by (a)  abnormal aminoacyl-tRNA,  ()  ribosomal malfunction.  Effect of
streptomycin.  The  problem  of  "reading"  a  nucleic  acid  template.  Different
ribosomal  mutants  and  DNA  polymerase  mutants  might  cause different  mis-
takes. The possibility of involvement  of  allosteric proteins in template reading.
Barely  21  years  after the great discovery  of Avery,  MacLeod,  and McCarty,
indicating  that nucleic  acids might  carry hereditary  information  (1),  we are
confident that we understand the broad outlines of the chemical steps through
which the information encoded in the nucleotide sequence of DNA is expressed
in the form of protein.  In the time available I can give only a short and neces-
sarily superficial draft of some concepts  of protein synthesis  and  try to point
out a selected few  of the gaps in our knowledge.
Steps in Protein Synthesis.  The Nature of the Genetic Code
The first  step in  protein  synthesis  (Fig.  1)  is  the transcription  of DNA into
messenger  RNA  (2)  complementary  to  one  of the  two DNA strands  (3,  4).
This is catalyzed by RNA polymerase  (5-7).  The second step will be the topic
of this discussion and we will return to it subsequently.  The third step is  the
folding  of the  peptide  chain  into  a  3-dimensional  biologically  active  form.
We have  come  to believe  that the  3-dimensional  structure  is  determined  by
the amino acid  sequence.  This belief is based  on  the following  observations:
enzymes  can be denatured,  that is,  their 3-dimensional  structure  destroyed,
leading  to  loss  of their  biological  activity.  It  was  demonstrated  in  several
cases  that under  proper conditions  denatured  enzymes  regain  their  activity
and  3-dimensional  structure  (8).  This indicates that the  3-dimensional  struc-
ture of the active protein (including  its disulfide bonds,  if any)  represents the
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most  stable conformation  of its  polypeptide chain  under physiological condi-
tions.
In  the second  step, called translation,  the sequence of four kinds of nucleo-
tides  in  mRNA  serves  as  the  template  for ordering  the  sequence  of the  20
kinds of amino  acids into a polypeptide chain.
The code  used in this  translation  is  quite simple.  Since  20 kinds  of amino
acids have  to be specified  by 4 kinds of nucleotides,  at least 3 nucleotides are
needed to specify one amino acid. A nucleotide  sequence  specifying an amino
acid  is  called  a  "codon."  Each  nucleotide  participates  in  one  codon  only.
This conclusion follows from the finding that a point mutation, i.e. the replace-
ment  of a single nucleotide,  leads to the  replacement of a  single  amino acid
(9,  10).  The order of mutations  in the genetic map is the same as the order of
amino  acid  replacements  caused  by  these  mutations  in  the  peptide  chain:
the  genetic  map  and  the  peptide  are  colinear  (11,  12).
Dr.  Hogness  discussed  in  this  symposium  experiments  correlating  length
of DNA fragments  with distance  on  the  genetic  map.  His results  show that
transcription  translation  folding
DNA  - t  RNA - t  polypeptide  - active  protein
chain
FIGURE  1.  Steps in protein synthesis.
the  order of genes  (on the  genetic map)  is  the  same as the  order of polynu-
cleotide  blocks  chemically  "incarnating"  them  (in  DNA);  i.e.,  colinearity
between  the genetic  map  and  DNA  (see  also  reference  13).
That a  codon  consists  of 3  nucleotides  was  first  shown by genetic  experi-
ments with proflavin mutants  (14,  15). Proflavin is a mutagen which can cause
insertion  into or deletion from DNA  of a nucleotide during DNA replication.
Crick et al. recombined  sets of properly selected proflavin mutants of a single
gene. While insertion  (or deletion) of 1, 2, 4, or 5 nucleotides from a functional
gene always led to an inactive  gene product,  insertion  (or deletion)  of 3  or 6
nucleotides led to an active gene product. Presumably,  the gene into which  3
nucleotides are inserted,  causes  the formation of a biologically  active protein
one  amino acid longer  than the  wild-type  protein.  If  1 or 2  nucleotides are
inserted  (or  deleted),  the  triplet reading frame  will be  shifted into an incor-
rect position and will specify a different peptide from the insertion point to the
end of the gene. These results indicate that codons are nucleotide triplets and
that the  sequence  of nucleotides  is  translated  triplet  by triplet  from  a  fixed
starting point  (14,  15).
How do the codons actually  specify  amino acids?  It  was  first believed  that
there might be a stereochemical  fit between the side  chain of an amino acid
and  the  group  of nucleotides  which  specifies  the  amino  acid  (16)  (see  also
reference  17).  Crick  argued,  however, that  such  a fit  was  unlikely.  He sug-
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gested that since nucleotides have specific hydrogen-bonding sites, they should
be recognized  by these and predicted  the  existence  of adaptor  molecules  as
the tools of this recognition  process  (18).
The adaptors,  subsequently  discovered,  turned out  to  be a kind of RNA,
consisting of about  80  nucleotides,  and  were called transfer RNA  (19).  One
of the most remarkable achievements  in biology announced  this year was the
complete nucleotide  sequence determination of alanyl-tRNA  from yeast  (20).
Each adaptor is specific for one amino acid and is believed  to have a portion
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FIGURE  2.  Diagrammatic  representation of  the structure of  the  E. coli  70S  ribosome
(23).
consisting of a nucleotide  sequence  complementary  to the  codon  specific  for
the  amino  acid  carried  by  the adaptor.  This  hypothetical  sequence  is  the
anticodon.
The  nucleotide  sequence  of  yeast  alanyl-tRNA  permits  formation  of  a
structure  with  several  loops  connected  by  double-stranded  regions  (20).
Identification  of the  hypothetical  anticodon,  determination  of the  3-dimen-
sional structure  of tRNA, and assignment of functions  to different portions of
tRNA are still outstanding.
The enzymes  attaching  amino acids  to tRNA are called  aminoacyl-tRNA
synthetases  (21). The reaction  they catalyze is the following:
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amino  acid1 +  ATP  +  enzyme  z  aminoacyll-AMP-enzymel  +  PP
aminoacyll-  AMP-  enzyme +  tRNA1 =  aminoacyll  - tRNA1 +  enzyme
+  AMP
In  the  above  equations,  enzyme 1 stands  for  aminoacyl-tRNA  synthetase
specific for amino acid1.
Each  aminoacyl-tRNA  synthetase  appears  to  be  specific  for  one  amino
acid.  In line with  the adaptor  hypothesis,  it was demonstrated  that after  an
amino acid was attached  to tRNA the coding  specificity  resided solely in the
FIGURE  3.  Schematic  representation  of the  stepwise  growth  of  the peptide  chain  on
the  ribosome.
1. The COOH terminal  amino  acid  (aaa)  of the peptide  is attached to tRNA3. The
peptidyl-tRNA  is bound to the ribosome.  aa4tRNA4 specified  by (n  + 1) codon is bound
to the ribosome  through  hydrogen  bonding  between the  codon and  the  anticodon.
2.  aa3 forms a peptide linkage through its COOH  group with the NH2 group of aa4 .
tRNA 3 is released.
3.  The ribosome moves  3 nucleotides along the mRNA.  aastRNA5 specified  by codon
(n  +  2)  is bound to the ribosome.
tRNA  component.  When  cysteinyl-tRNA  was  converted  to  alanyl-tRNA,
the incorporation  into  protein  of  this  alanine  attached  to  cysteine-specific
tRNA was still promoted  by a codon  specific for cysteine  (22).
Polymerization  of the aminoacyl  moieties  of the  aminoacyl-tRNA's  into  a
peptide occurs on the surface  of the ribosome.  Ribosomes  are complex struc-
tures  (Fig.  2),  and  at  this  time  we  cannot  assign  functions  to  their  many
components  (23).  Ribosomes  are attached  to mRNA  through  their 30S sub-
unit  (24).  The  mRNA-30S  ribosome  subunit  complex  can  specifically  bind
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aminoacyl-tRNA  (25,  26).  For  example,  a  poly  U-30S  ribosome  subunit
complex binds phenylalanyl-tRNA.  A single  codon,  a triplet,  is sufficient  to
direct  specific  binding  of  aminoacyl-tRNA  to  the  ribosome  (27).
The growing polypeptide  chain, which is bound to tRNA through its termi-
nal carboxyl group, seems to be attached to the 50S subunit (28). This attach-
ment is not known to require mRNA. The growth  of the peptide chain starts
with the  amino terminal amino  acid and  continues  stepwise,  amino acid  by
amino acid, toward  the carboxy terminal amino acid  (29,  30).
Fig.  3  illustrates aminoacyl-tRNA,  specified by the forthcoming  codon,  in
process  of being attached  to the mRNA  ribosome  complex.  A peptide  bond
is  formed  between  the  carboxyl  group  of the carboxy  terminal  amino  acid
and  the  amino  group  of the  new  amino  acid  attached  to tRNA.  This  step
requires  participation  of at  least  two  transfer  enzymes  (31-33),  and GTP.
One  GTP  molecule  is  split  into  GDP  and  orthophosphate  for  each  amino
acid attached to the peptide chain  (34).  Several ribosomes  moving along and
translating  the same mRNA  at one time  form a so-called  polyribosome  (35,
36).  The half-life  of mRNA  varies  from a few minutes  (certain mRNA's  in
bacteria,  37)  to essentially stable mRNA  in reticulocytes specifying hemoglo-
bin  (38).
Evidence has  been provided that tRNA and ribosomal  RNA  are  synthe-
sized on  the DNA template  (39-41).
The Deciphering of the Code
The actual  deciphering  of the  code  was  based  on  the  following  conceptual
insights  and experimental  achievements.
For some  time  ribosomal  RNA  itself was  assumed  to  be the  template  in
protein synthesis. Jacob and Monod  (2)  pointed out that this could not be the
case,  since  while ribosomal  RNA  in  bacteria  was metabolically  stable  (42),
synthesis of inducible enzymes  (i.e. new proteins) rapidly started or ceased on
addition, respectively  removal,  of inducer  to  (or from) the  bacterial  culture.
This  and  other  considerations  prompted  them  to  predict  the  existence  of
mRNA carrying the information  from DNA to the ribosomes.  They suggested
that ribosomes  are  nonspecific,  could  participate in  the synthesis  of any pro-
tein,  and  that it was  the  function  of mRNA  to  attach  to  the  ribosome  and
program  it for the synthesis  of a particular  protein.
A cell-free  amino acid-incorporating  system was developed  along the path
laid down  by the pioneer work of Zamecnik  and Keller  (43).
Grunberg-Manago  and  Ochoa  discovered  polynucleotide  phosphorylase,
an  enzyme  which  can  polymerize  any  kind  of ribonucleoside  diphosphate,
singly or mixed,  into long polyribonucleotide  chains  (44).
Reaping  the  harvest  of all  the  above  findings,  Nirenberg  and  Matthaei
were  the  first  to  use  synthetic  polynucleotides  as  messengers  in  a  cell-freeAPPROACHES  TO  THE  BIOSYNTHESIS  OF  MACROMOLECULES
amino  acid-incorporating  system.  They  found  that  a  homopolynucleotide
(poly  U) promoted the formation  of a homopolypeptide  (polyphenylalanine)
(45)  (Table  I).  Lengyel,  Speyer,  and  Ochoa  established  that  copolynucleo-
tides consisting  of 2 or 3 kinds of nucleotides  in a random sequence promoted
the incorporation  of several  amino acids; i.e.,  they caused  the formation  of a
copolypeptide  (46).  The kinds  of amino  acids  incorporated  into the  copoly-
peptide  depended  upon  the  kinds  of  nucleotides  present  in  the  copolynu-
cleotide used  as  messenger;  furthermore,  the  ratio of amino  acids  in the  co-
TABLE  I
HOW  SYNTHETIC  OLIGO-  AND  POLYNUCLEOTIDES  HAVE  BEEN  USED
IN  THE  IN VITRO  SYSTEM  TO  DECIPHER  THE  CODE
Poly  U  Polyphe
Poly  A  Polylys
Promoted
Poly AC  (5:1)  Lys-thr-asn-gln-his -pro
(100  26  24  24  6  7
Poly  AC  (1:5)  formation  ?Pro-thr-his-asn-gln\ 
k10021  235  5
Poly  (UC)  of  (Ser-leu),
Poly  (AAG),  Polyarg,  polygln,  polylys
UUU  Promoted  Phe-tRNA
attachment
UCG  to ribosomes  Ala-tRNA
of
* The numbers  indicate relative  amounts  of amino  acids  incorporated into  a  random  copoly-
peptide.  For  references  see  the  text.
polypeptide  product depended  upon  the  base ratio of the  copolynucleotide.
The study with random  copolynucleotides  as messengers  led to the  elucida-
tion  of the  nucleotide  composition  of about  50  codons  (47,  48).
The  sequence  of nucleotides  within  codons  has  been  (and  is  being)  es-
tablished  mainly  by two  methods:  Nirenberg  and  his  colleagues  have been
using  their  elegant  technique  promoting  the  specific  binding  of aminoacyl-
tRNA  to  ribosomes  by  nucleotide  triplets  (27,  49)  (see  also  reference  50).
Khorana and his collaborators  developed  in the  last few  years  the chemical
and  enzymatic  methods  for synthesizing  chemically  defined  polynucleotides
with repeating  oligonucleotide  sequences  and  have  been  using  the  latter as
messengers  in cell-free  amino acid-incorporating  systems  (51).  They found,
for  example,  that poly  (UC)  (consisting  of a repeating  UC sequence)  pro-
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moted the formation of a polypeptide  consisting of an alternating sequence  of
leucine  and  serine  residues  (52).  Poly  (AAG),  promoted  the  formation  of 3
homopolypeptides:  polyarginine,  polyglutamic  acid,  and  polylysine  (53).
These results  strongly support  the  triplet nature  of the  code.  The great  sig-
nificance  of Khorana's  studies  with chemically  defined  messengers  is  partly
due  to  the  shortcomings  of  the  method  of aminoacyl-tRNA  binding to  the
ribosome triplet complex:  there are certain triplets which for unknown reasons
TABLE  II
THE  GENETIC  CODE
2nd nucleotide  of codon
ist nucleotide  3rd  nucleotide
ofcodon  U  C  A  G  of codon
Phe  Ser  Tyr  Cys  U
Phe  Ser  Tyr  Cys  C
Leu  (?)  Ser  Nons*  (?)  A
Leu  Ser  Nonsj  Try  G
Leu  Pro  His  Arg  U
Leu  Pro  His  Arg  C
Leu  (?)  Pro  Gin  Arg  A
Leu  Pro  Gin  Arg  G
lieu  Thr  Asn  Ser  (?)  U
Ileu  Thr  Asn  Ser (?)  C
Ileu  (?)  Thr  Lys  Arg  A
Met  Thr  Lys  Arg  (?)  G
Val  Ala  Asp  Gly  U
Val  Ala  Asp  Gly  C
Val  Ala  Glu  Gly  A
Val  Ala  Glu  Gly  G
*  Also called  ochre codon.
t Also called  amber codon.
do not promote  aminoacyl-tRNA  binding,  though  some  of them, when  oc-
curring  in  polymers,  do  promote  amino  acid  incorporation.  The  binding
promoted by some other  triplets  is not very far above  the background  level.
Finally,  some triplets promote binding of several aminoacyl-tRNA's  (49,  50).
The Structure of the Code
The code,  as it is known in the fall of 1965, is shown in Table II  (49, 50). The
question marks in the table indicate that the experimental  basis for the triplet
assignment  is  weak  or nonexistent.  The  pattern  emerging  is  the  following:
most amino  acids  are  represented  by several  triplets;  i.e.,  the code  is highly
degenerate.  Codons  representing  the  same amino  acid are  called  synonyms.
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Synonym  codons  usually  differ  only  in  the  third  nucleotide.  In  this  third
position of the codon,  U  is equivalent  to C  (e.g. both  UUU and UUC  code
for the same amino acid: phenylalanine)  in all cases  so far; A is equivalent to
G in most  cases;  and  all  4 nucleotides  are equivalent  in several  cases.  This
pattern  could be due to evolutionary  causes. If at an earlier stage the codons
were  doublets  coding  for  15  amino acids  only, and  later  the code expanded
into its present triplet form specifying  20 amino  acids,  the nucleotides  in the
first and second position of a triplet specifying one of the 15 amino acids might
TABLE  III
THE  WOBBLE  HYPOTHESIS
The  most likely recognition  set  between  the  third nucleotide  of the  codon
and  a nucleotide  of the anticodon  (56).
Nucleotide  recognized  on codon
Nucleotide  of anticodon  (in third  position)
~~~U  A
G
C  G
A  U
G  U C
U
I  C
A
still be the same  as they were in the doublet code.  Addition of the  third nu-
cleotide split the specificity  of some of these doublets into  two in order to be
able  to specify  5 more amino acids  (54).  Obviously,  it is difficult to  provide
evidence  for such an evolutionary hypothesis.
On  the other  hand,  the particular  relationship  of synonym  codons  might
be due  to a feature  of the  translation  mechanism.  Evidence  in favor  of  this
view  is accumulating.  Highly  purified  alanyl-tRNA  from  yeast  is  bound  to
ribosomes in the presence of all 4 alanine codons having G and C in the first,
respectively second position  (49). Most of the phenylalanyl-tRNA  from E. coli
is bound to ribosomes with either UUC or UUU triplets  (55). The above find-
ings might  indicate  that base complementarity  in the  standard  sense  might
not be an absolute requirement for pairing between the codon  and the hypo-
thetical anticodon.  Crick suggests  that while the standard  base  pairs may be
used rather strictly in the first two positions of the triplet,  there may be some
"wobble;"  i.e.,  more  relaxed  complementarity  requirements  in  the  pairing
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of the third nucleotides  (56).  Among several  alternatives offered, he prefers a
pattern  in which  the recognition  set  shown in  Table  III  exists  between  the
third nucleotides  of codon  and anticodon.  The suggestion of I as a third nu-
cleotide  of the  anticodon,  capable  of recognizing  U,  C,  or A  (or even G)  is
based  on  the  finding  of Holley  that I  occurs  in alanyl-tRNA  adjacent  to G
and  C and could well  be part of the anticodon  (20). The rules of "wobbling"
between  the third  nucleotides  might  well  be  the  cause  for  the relationship
pattern between  synonym codons.
TABLE  IV
DETERMINATION  OF  THE  NUCLEOTIDE  SEQUENCE  OF  A
NONSENSE  CODON  FROM  AMINO  ACID  REPLACEMENTS
RESULTING  FROM  MUTATIONS  OF  THE
NONSENSE  CODON  (62)
Nonsense  codon  Related  codons
AAG  UCG  UAC
(lys)  (ser)  (tyr)
UAG  CAG  UUG  UAU
(gin)  (leu)  (tyr)
GAG  UGG  UAA
(glu)  (try)  (nonsense)
Initiation and Termination of the Peptide Chain
One mRNA  molecule  might  serve  as a template  for the synthesis  of several
kinds of polypeptides;  i.e., might be polycistronic  (57,  58).  In consequence  of
this, there  is a need  for a signal  (or signals) in mRNA  to indicate  where the
synthesis of the peptide chain should be finished and the synthesis of the next
polypeptide started.  It is not obvious whether  such signal(s)  are required  for
the translation of the actual beginning and of the end of the mRNA chain too.
Some codons do not seem to specify any amino acid in certain E. coli strains.
They are  referred  to  as nonsense  codons.  If such  a  nonsense  codon  is  gen-
erated  in a cistron  (59, 60),  the mRNA of the cistron  will be translated  into a
peptide only from its 5' end to the nonsense triplet; i.e., nonsense codons cause
chain termination in peptide synthesis  (12).  The nucleotide  sequences of two
such  nonsense  triplets  were  deciphered  as  UAG and  UAA  in  a  study  with
specific  mutagens  (61).  Another  study  in  which  different  amino  acid  sub-
stitutions were  analyzed  occurring  at the same  position of the peptide  chain
and resulting  from  the reversion  of the  same  nonsense  mutation  led  to  the
same  conclusions  (62,  63).  As illustrated  in Table  IV, the codon assignment
for all the substituting amino acids can be related by single base changes only
to a UAG nucleotide  sequence.
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Most  of the  peptide  product  formed  in  the  cell-free  E. coli  system  with
natural  mRNA  (like phage  RNA or endogenous mRNA)  is free polypeptide
(64).  In contrast to this, many synthetic polynucleotides  promote  the forma-
tion mostly of peptidyl-tRNA  still attached to the  ribosomes.  With synthetic
polynucleotides  containing  both  U and A  in proper  ratios,  more than  50%
of the peptide product  is in the form of free polypeptide  (64,  65).
The  amino group  of the  amino  terminal  amino  acid  of many proteins  is
acetylated. However, the need for the acetyl residue in peptide chain initiation
was made unlikely  by the finding  of an  enzyme  acetylating  several  finished
proteins having different  amino terminal  amino  acids  (66).  Detailed  studies
could  not  establish  the  existence  of either  acetyl  amino  acid  activation  or
acetate  transfer  to  aminoacyl-tRNA  in E.  coli extracts  (67).
47%  of the amino terminal  amino acids of the protein from cell-free  E. coli
extract  is  methionine,  26%  alanine,  and  26%  serine.  On  the  other  hand,
methionine  constitutes  only  2.5%  of  the  amino acid  in  the protein  of this
extract  (68). It was of great interest, therefore,  when formylmethionyl-tRNA
was found  in E. coli extracts  (69).  It was  established  that formylation occurs
at the methionyl-tRNA  level and that while at least 2 methionyl-tRNA  frac-
tions  exist  in  E. coli,  at least  one  of these  cannot  be  formylated.  Poly UG
was found to promote incorporation of formylmethionyl-tRNA  into the amino
terminal position of peptides  (70).
The coat protein  of f2  phage has  alanine  as its amino terminal and serine
as its second  amino  acid. It was discovered  that the  coat protein synthesized
in the cell-free E. coli system with f2 RNA  as messenger starts with N-formyl-
methionine,  and  alanine is the  second,  serine  the third amino acid  (71,  72).
This raises  the intriguing  possibility that  N-formylmethionine  might  be  the
compulsory  chain-initiating  amino  acid  in E. coli in vivo.  That  formylme-
thionine  is not found  as amino terminal of all E. coli peptides might be due
to subsequent removal of formate, or formylmethionine  (or even more amino
acid  residues)  from  these proteins.  If formylmethionine  or any  other  amino
acid  with  a  blocked  alpha  amino  group  is  the chain  initiator,  there  is  no
necessity  to have  special  signals  for  chain termination.  Since  formylmethio-
nine cannot form a peptide bond through its blocked amino group,  wherever
it is  coded  for  in a  polycistronic  mRNA,  it might serve at the  same time  as
chain terminator and chain initiator. In vitro chains can be initiated without
formylmethionine,  since, e.g. phenyllactyl-tRNA  (synthesized by deaminating
phenylalanyl-tRNA)  can serve as the source  of the amino terminal moiety of
the peptide chain, and phenyllactic acid has no amino group to which another
amino acid could have been  originally linked  (73).
The direction of translation of mRNA  (15,  74-76)  is the same as the direc-
tion of its  synthesis; i.e.,  from  the  5'  end to  the  3' end  (77,  78).  This being
so,  it is possible  that translation  might be started while  the mRNA  is being
built.
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Mathematicians  and theoreticians  had speculated  about a very fancy and
complicated  code  structure  (see  reference  79).  It turned  out  to be  simpler
than  one  dared  to hope  for.  Not  only was  the  simplest  messenger  a  homo-
polynucleotide,  not only did  a single codon,  a  triplet, suffice  to promote  the
binding of aminoacyl-tRNA  to  the  ribosome,  but  recently  it  was  reported
that the shortest possible messenger,  consisting  of only two codons,  promoted
peptide formation.  A3U3 caused  the formation  of some lysylphenylalanine  in
a cell-free  system  (75).
MISTAKES  IN  PROTEIN  SYNTHESIS.  AMBIGUITY  AND
SUPPRESSION
Under the heading of mistakes in protein synthesis,  we will consider cases  in
which  the same codon  is translated  in more  than  one way.  It was observed
that  poly  U  promotes  in  vitro  the  incorporation  into  peptide  not  only  of
phenylalanine,  but also of smaller  amounts of leucine, isoleucine,  serine,  and
tyrosine  (80-82).  This  phenomenon,  called  ambiguity,  was first  thought  to
be an  artifact of the cell-free  system.  Since similar  phenomena  were  noticed
in vivo,  it was realized  that ambiguity  was an inherent characteristic  of the
protein-synthesizing  machinery  of the  cell.  A  mutation  which  restores  the
function  of a  gene inactivated  by a  previous  mutation is called  a suppressor
mutation.  There is  a class of suppressor mutations which  cause ambiguity in
translation  (83,  84). A  clear example  of this was described for the  case of E.
coli  tryptophan  synthetase  A  (85).  There  is  a  glycine  residue  in  a  certain
position of the peptide  chain of the wild-type  enzyme.  As a result of a point
mutation,  the  same  glycine  is replaced  by arginine;  this  altered  enzyme  is
inactive,  therefore,  the cell  becomes tryptophan-requiring.  A suppressor  mu-
tation  occurring  in  a distant part of the  genome  (outside  of the  structural
gene for this enzyme)  causes the cell  to produce two kinds of tryptophan syn-
thetase A:  10%  identical with the wild-type  enzyme (with glycine),  and  90%
in  the  inactive  mutant  form  (with  arginine).  In other  words,  as  a  result  of
suppressor  mutation,  the triplet,  which  specifies  only  arginine  in  the  strain
without  suppressor  activity,  will  be  mistranslated  into  glycine  in  10  cases
out of a 100 in the strain with an active suppressor.  The suppressed mutant is
able to grow without added tryptophan.  This phenomenon is called missense
suppression.
We  discussed  earlier that in certain  strains of E.  coli the  UAG  and  UAA
triplets do not specify any amino acid,  but behave as signals for chain termi-
nation.  In other  E.  coli strains,  harboring  particular  suppressor  mutations,
these nonsense triplets are translated  to a varying extent into different amino
acids.  The kind  of amino acid  specified  and  the  efficiency  of translation de-
pend  on the suppressor  mutation  (86-89)  (Table V).  It is unlikely  that the
UAG triplet should  be the real chain-terminating  signal in vivo, since strains
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is expressed  (61,  90), grow with a normal generation time. It is possible, how-
ever, that UAG  (or UAA) might be starting portions of the real chain-termi-
nating signal. If that was so, one might expect to find that the carboxy termi-
nal  amino acid of proteins was more  frequently serine in a  strain having an
efficient nonsense  suppressor inserting  serine than in strains lacking  this sup-
pressor.  It  is  of interest  that suppression  itself can  be ambiguous,  since  the
same suppressor  translates two different triplets.
Limitations in the  Universality of the Code
It is  a widely accepted conclusion  that the code is universal in Nature.  Some
findings which support this conclusion are: the alkaline phosphatase structural
gene of E. coli, if introduced into Serratia  marcescens, causes the formation of the
TABLE  V
SUPPRESSION  OF  NONSENSE  CODONS  (86-89)
Nonsense  codon
Suppressor  UAG  UAA
Su - Chain termination  Chain termination
Su  I  Ser  Chain termination
Su 2  Gin  Chain termination
Su 3  Tyr  Chain  termination
Su 4  Neutral  amino  acid  Neutral amino  acid
Su 5  Basic  amino  acid  Basic  amino  acid
E.  coli alkaline  phosphatase  in  its  new host  (91).  Satellite  tobacco  necrosis
virus RNA, used as messenger in a cell-free E. coli system, promotes the forma-
tion of a protein which seems to be the same as its normal coat protein formed
in  the  tobacco  plant  (92);  vaccinia  virus  is  formed  in  Bacillus subtilis cells
infected with vaccinia DNA  (93).  The fact,  however,  that the  same triplet  is
translated  in different  ways in different strains  of the  same  species sets limits
to the universality of the code.
Attempts to Establish Which Codons Occur in a Species
The  codons  established  in  studying  synthetic  messenger-promoted  amino
acid  incorporation  and  triplet-promoted  aminoacyl-tRNA  binding  to  the
ribosomes  in the  cell-free  system of a given  species  are the  codons which this
species is able to translate.  It does not follow, however,  that all these codons
occur in its mRNA's  (94).  The availability  of suppressors for nonsense muta-
tions makes it possible  to attempt the solution  of this problem. To determine
which  codons  do actually  occur  in  a  species,  we  have to  study  mutational
amino  acid replacements  and  establish  which  of the  possible  codons  fit  the
amino acid replacement  pattern. Alkaline  phosphatase  of E. coli contains  40
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glutamine and/or glutamic  acid and  25 lysine residues per subunit  (95). Ac-
cording to the list of codons  (Table II) lysine can be coded by AAA and AAG,
glutamic acid can be coded by GAA and GAG. To find out whether all these
codons do occur in the alkaline phosphatase  structural gene of E. coli, a large
number of nonsense  codons were  generated in this gene  (62,  63,  96).  Fifteen
of these nonsense codons  (each at a different site) were identified as UAG and
15  were  identified  as  UAA  by  their response  to  different  suppressor  genes.
The electrophoretic  mobilities  of the  enzyme protein  of the suppressed  non-
sense mutants, having a neutral amino acid specified by the nonsense condon,
were  compared  with  that of the wild-type  enzyme.  The mobility  of all  the
proteins  containing  a  UAG codon  (suppressed  by the insertion of a neutral
amino acid)  was the same as that of the wild-type enzyme. Thus,  it was con-
cluded that the original  triplets,  from which the UAG triplet arose by muta-
tion, specified  only neutral amino acids, and none  of them specified lysine or
glutamic  acid.  On the other hand,  similar  experiments led  to the conclusion
that about  half of the  UAA  codons  arose  from  triplets  specifying  lysine  or
glutamic  acid in  the wild type.  These  studies suggest that the AAG  and the
GAG  triplets  occur  rarely  (or  not at  all)  in  this  gene;  the  primary lysine
codon appears to be AAA, and the glutamic acid codon GAA. The UAG non-
sense triplet was,  however, found  to revert in single step mutations to triplets
specifying  lysine or glutamic acid. This result shows that E. coli can translate
the AAG and  GAG codons.  It would  be premature  to jump  to general  con-
clusions  concerning  the  actually used  codon  set of E. coli.
How could one synonym codon be preferred to the  other if both  are recog-
nized by the same  tRNA? The answer to this question  is probably indicated
in  the  observation  that  the  binding  of  a  specific  tRNA  to  the  ribosome  is
more stimulated  by one synonym codon  than by the other synonyms  (49).
How do  the Mistakes in  Translation Arise?
What  is known  about the  mechanism  of mistake formation?  Which  compo-
nents of the protein-synthesizing  machinery  are  to be blamed?  The possible
mechanisms can be grouped into two classes: in one class the binding between
codon and  anticodon is correct;  i.e., complementary  in the classical  sense be-
tween the first, respectively  second nucleotide  pair, and  complementary with
the permitted wobble between  the third nucleotide pair.  (It should not be for-
gotten that the anticodon is still a hypothetical entity.)  In this class the faulty
component  is aminoacyl-tRNA,  more precisely, the amino acid is attached to
a tRNA with an anticodon not specific for the amino acid. This might result,
for example,  from a mutational  change  in  the anticodon  of the tRNA itself,
or  a faulty  activating  enzyme  loading  an  amino acid  on the  wrong  tRNA,
or a modification  of the aminoacyl-tRNA  by some other faulty enzyme,  etc.
In  the light  of the  wobble hypothesis  (56)  (Table  III)  a mutation  in  the
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third position  of the  anticodon replacing a C  (which only pairs with G) by a
U  (which pairs both with A and  U) might lead to an ambiguous  suppressor.
In  this  context,  it  is  not  without  interest  that  while  there  are  suppressors
specific  for  UAG  alone,  suppressors  for  UAA  also  suppress  UAG  (61,  89).
This might turn out to fit the  wobble hypothesis,  according  to which  in the
third position  of a codon G can be specified  separately  from A; however, A is
specified  together  with G  (or with U and C).
The  experimental  proof  for a  tRNA being  the  culprit  in  the  case  of the
suppressor  inserting  serine  in response  to the  UAG  triplet  was provided  re-
cently  (97,  98).  It was established that the RNA from an R17  phage mutant,
containing  a  nonsense  codon,  does  not  promote  the  formation  of  its  coat
protein in a cell-free  system derived from an E. coli strain not having the sup-
pressor.  However,  when  serine-specific  tRNA  from  a  strain  containing  the
suppressor  was added to the  above  inactive  system,  the same  RNA  from the
mutant phage  became  a good  messenger  for coat  protein formation.  As  dis-
cussed  earlier,  it is  not  clear  whether  the  suppressor  mutation  affected  the
serine-specific  tRNA  directly  or  indirectly.
A second class of mistake mechanisms  involves  mismatching  in the codon-
anticodon recognition; i.e., binding to a codon ribosome complex of an amino-
acyl-tRNA  with an  anticodon  not complementary  to the  codon  in question
(82).  Actually,  it was shown  that all  the isoleucyl-tRNA  of E.  coli could  be
bound to a poly U ribosome complex when the tRNA concentration  was suffi-
ciently  low  (99).  The  extent  of this  kind  of mistake  in  the  in  vitro  system
decreases  with increasing tRNA concentration  (99,  100).  This indicates  that
the tRNA,  the anticodon of which is complementary  to the codon promoting
its  attachment  to  the ribosome,  is  a  better competitor  for binding  than the
tRNA,  the anticodon  of which  is only partially complementary  to the codon.
It is most unlikely thai this kind of base-pairing mistake could be attributed
to  faulty aminoacyl-tRNA  or  activating  enzyme.  As  long  as  these  mistakes
were only found in the in vitro system it was possible to blame the biochemist
for  selecting  poor conditions for his experiments  or damaging  components  of
the cell-free  extract.  It became  obvious, however,  that the same kinds of mis-
takes  do  occur in vivo too.  It turned  out that the source  of such  mistakes in
vivo was a malfunction of the ribosomes  (101).  This unexpected finding came
to  light  in a  somewhat  roundabout  way.
The Role  of Ribosomes.  The  Effect  of  Streptomycin  on  Translation
First it was established  that ribosomes  are the  (or at least a)  site of action  of
streptomycin.  This  was  predicted  (102)  and  then  verified  by the  following
experiment:  poly  U-promoted  phenylalanine  incorporation  in  vitro  was
inhibited by streptomycin  if the  ribosomes  in  the system  were  taken  from a
streptomycin-sensitive  strain.  It was not inhibited  if they were  taken  from  a
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streptomycin-resistant  strain.  It made  no  difference  whether  the  source  of
the supernatant was a sensitive or a resistant strain  (103,  104).  Subsequently,
the  site  of action  was  further  narrowed  to the  30S  subunit  of the ribosome
(105),  and it was also shown that the genetic  marker determining streptomy-
cin sensitivity or resistance  was cotransducible  (certainly closely linked, if not
identical)  with a gene specifying  a protein of the 30S  subunit  (106).
Second, streptomycin was found to act like a suppressor mutation. Actually,
it  was  found  that  certain  arginine-requiring  bacterial  mutants  lacking  one
of the  enzymes  (ornithine  transcarbamylase)  of the  arginine  pathway grew
without arginine if streptomycin was added to the medium.  It was shown that
under  the latter  conditions  some ornithine  transcarbamylase  was formed  in
the cell  (107).  Certain kinds of suppression are due to mistakes in translation,
and it was established that streptomycin  increases  the  ambiguity of the cell-
free  system  (101),  causing  mismatching  in  the  codon-anticodon  recognition
process  (99).  Streptomycin  is an aminoglycoside antibiotic.  It was found  that
other members  of this class also  cause mistakes  in translation  (101).  There is
even some specificity  in the action of the different  aminoglycoside  antibiotics:
streptomycin  stimulates  poly  U-dependent  incorporation  of isoleucine,  but
not of tyrosine; neomycin  stimulates  that of tyrosine  (108).  Neomycin causes
not only mistakes in the recognition of the purine, pyrimidine bases, but even
of the  sugar  component.  In  its  presence,  denatured  (single-stranded)  DNA
acts  as a messenger  (109).
The fact that streptomycin,  known to act on the ribosome,  causes  binding
of the wrong aminoacyl-tRNA  to the mRNA ribosome complex and increases
the  mistake level  in  translation  indicates  that it might  be  a  function  of the
ribosome  to  permit  only binding  of the codon  with the matching  anticodon
carrying  tRNA.  Ribosomes,  which  are  distorted  (for  example,  by  strepto-
mycin),  however,  permit  binding  to  each  other  of  a  nonmatching  codon-
anticodon  pair  (99,  101).  The above  conclusion  was  reinforced  when it was
established  that "miscoding"  and,  thus, the  presumed distortion  of the ribo-
somes, does not have to be caused  by an external agent. Actually it was found
testing the  poly U-promoted  isoleucine  and  serine  incorporation  in  the  ab-
sence  of streptomycin,  that streptomycin-resistant  ribosomes  were  only  one-
tenth  as ambiguous  in vitro  as  streptomycin-sensitive  ribosomes  (110).  Thus,
in  essence,  ribosomes  with  a  different  structure  differ  in  their  accuracy  of
translation.
The  opposite  approach,  which  attempted  to  show  that cells  harboring  a
suppressor  mutation  might  have  ribosomes  with  a  different  structure  from
that of ribosomes of the wild-type cell, was reported to be successful. The disc-
electrophoretic  pattern  of  ribosomes  from  a  strain  containing  a  suppressor
(arisen  by a  single  step  mutation  which  suppresses  a  nonsense  mutation  in
the beta galactosidase gene) was claimed  to lack one protein band which was
present  in  the  strain  not  having  the  suppressor  (111).
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Different  Ribosomal  Mutants Might Cause Different  Translation Mistakes
The most intriguing aspect of this story is that the different ribosomal mutants
do not just increase  the  mistake  level,  but  they  behave  like  allele-specific
suppressors.  Different  ribosomal  mutants  cause  (at  least  predominantly)
different  mistakes  in  the presence  of streptomycin.
This conclusion  was based  on  the following  experiments  (110):  the  E.  coli
strain  used was  streptomycin-sensitive  and  had a mutation in the  ornithine
transcarbamylase  gene which was suppressible by streptomycin.  A number of
streptomycin-resistant  mutants  originating  from  this  strain  were  isolated.
These  mutants were  divided  into:  (a) one  set  in which  the  mutation  in or-
nithine  transcarbamylase  was  still  suppressible  by  streptomycin,  and  one
set (b) which lost the suppressibility.  In a subsequent step, further auxotrophic
mutants were  selected from strains of each set.  On testing  these new strains  it
turned  out that there occurred  streptomycin-suppressible  auxotrophic  muta-
tions  in  both  sets,  thus,  even  in  (b),  in which  the  original  ornithine  trans-
carbamylase  mutation was not suppressible  by streptomycin  any more. This
indicated  that  the  mutant  ribosomes,  which  mediated  the  effect  of strepto-
mycin,  behaved  like  allele-specific  suppressors.  It was also  established  by in
vitro  studies  that ribosomes  from  different  strains  are  different  in  their  re-
sponse  to the misreading  action  of streptomycin  on the incorporation  of par-
ticular  amino  acids.  For  example,  in  the  wild-type  (streptomycin-sensitive)
strain streptomycin  causes a 4.  1-fold  increase in poly U-promoted  isoleucine
incorporation,  and  an  8.4-fold  increase  in  poly  U-promoted  serine  incor-
poration.  In one streptomycin-resistant  strain the corresponding  numbers are
12  and 2.6, in another streptomycin-resistant  strain both are around  1 (110).
The Problem of  Template Reading
The discussion  of all these  experiments  concerning  the function  of ribosomes
in translation  served  to emphasize  the  conclusion  that while "normal"  ribo-
somes  might  contribute  to  the  accuracy  of translation,  differently  distorted
"bad" ribosomes  (by  either action of an external agent or a mutation)  cause
different,  more or  less  specific  mistakes  in translation.  The function  of ribo-
somes  (performed  in  conjunction  with  the  transfer  enzymes)  is  in  essence
analogous to the function of RNA polymerase and DNA polymerase.  All three
are template-translating  machines with nucleic acids serving  as the template.
If normal  ribosomes  assure  the  accuracy  of translation  and  bad  ribosomes
make mistakes, could not bad DNA polymerase make mistakes in DNA repli-
cation? Attempting  to test  this possibility,  one has to take into consideration
that the percentage of mistakes caused by  a bad DNA polymerase might still
be  at or below  the limit which  can  be satisfactorily  picked up  by the  usual
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biochemical  assays.  With  the  much  more  sensitive  genetic  assays,  however,
this might be more feasible.
Testing  thermosensitive  mutants  of T4 phage,  which  have  the  mutation
in  gene  43,  the  gene  known  to  specify T4  DNA  polymerase  (112),  Speyer
found that some of these mutant phages had a 1000-fold  increased  mutation
rate compared to that of the wild type (113)  (see also reference  114). He found
that one  particular allele of mutant DNA polymerase  increased the reversion
rate of two amber  nonsense mutants  (of the r  region)  1000-fold  above  the
rate with the wild type. The same allele had no  effect on the reversion rate of
two  ochre  nonsense  mutations.  A  second  allele of DNA  polymerase  had no
effect  on  the  reversion  rate  of the  two amber  mutations,  but increased  the
mutation  rate of at least one  of the  two  ochre  mutations  to amber  800-fold
(115).  Thus, it seems that like bad ribosomes,  bad DNA polymerase  can also
cause  specific mistakes.
It is likely that some RNA polymerase  mutants might also make more mis-
takes in transcription  than the wild-type enzyme.
Streptomycin,  as discussed  at length,  seems  to act  by distorting  the  ribo-
somes and not by interaction with mRNA  or tRNA.  It is not  impossible  that
there  should  be  mutagens  which  exert  their  action  through  interaction
with DNA  polymerase  and  not with DNA.  It  is  not without  interest  that
streptomycin  itself  is  a  very  efficient  mutagen  for  nonchromosomal  genes
(116).
We  are  used  to  taking it  for granted  that  in  the  read-out  of a  template
nucleic acid the selection of each nucleotide being subsequently  built into the
new  chain  and  each  anticodon  in  protein  synthesis-occurs  through  direct
interaction  with  the  appropriate  nucleotide(s)  of  the  template.  This  is  a
simple and wonderful working  hypothesis.  There are analogies  to support it,
it explains many  findings,  but still it is,  as  of now,  a  hypothesis only which
would  warrant  any  effort  to  prove  it.  The  fact  that both DNA  polymerase
mutants  and  ribosomal  mutants  might  cause  specific  errors  in  template
reading  makes  one  wonder  whether  the  process  of  selecting  the  incoming
nucleotide  or  triplet is not mediated  through  allosteric  protein;  i.e.,  with  no
direct  interaction  whatsoever  between  template  and  incoming  nucleotide
(113,  117,  118). To cite just two facts which might be indications that such a
possibility  is not  completely absurd:  (a)  Enzymes  can recognize oligonucleo-
tides. This can be seen, for example, in the high specificity of DNA methylating
enzymes.  (See  the  contribution  of  Gold  (page  5)  this  Symposium.)  (b)
Oligonucleotide  sequences  can cause  allosteric  alterations  of enzymes  which
affect the specificity  of the latter. This conclusion is derived from the following
experiment: isoleucyl-tRNA  synthetase  can form not only the isoleucyl-AMP
enzyme  complex,  but  also  a  valyl-AMP  enzyme  complex  (119).  Loftfield
and  Eigner  (120)  studied  the  quantitative  aspects  of these  two reactions  by
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assaying  for aminoacyl  hydroxamate  formation  that occurs  according  to the
following reaction sequence:
Amino acid  +  ATP  +  enzyme =  aminoacyl  - AMP  - enzyme
+  PP
Aminoacyl  - AMP - enzyme +  hydroxylamine  --* aminoacylhydroxamate
+  AMP +  enzyme
They  found  with  purified  isoleucyl-tRNA  synthetase  that  if isoleucine  and
valine were present simultaneously  at  10-6 M  in a reaction mixture,  45 moles
of valyl hydroxamate were  formed for every  1000 moles  of isoleucyl hydroxa-
mate.  If they added  2 mg per ml of tRNA, only  5 moles of valyl hydroxamate
were  formed  for  every  1000  moles  of  isoleucyl  hydroxamate.  This  about
tenfold  increase  in  specificity  of  the reaction  resulted  from  the  alteration  of
the  Km  and  V  values  caused  by  the  tRNA  for  isoleucine  (120)  (see  also
reference  121).  2 mg of tRNA which was previously unloaded  and periodate-
treated  (and  possessed  less  than 0.3%  of its  original  capacity  to accept  iso-
leucine),  had  almost  the  same  effect  on the  hydroxamate-forming  reaction
as  1 mg of untreated tRNA.  Consequently the tRNA must have  increased the
specificity  of isoleucyl-tRNA  synthetase  through  changing  the  conformation
of the enzyme;  i.e.,  acting  as an  allosteric  effector.
After  discussing  how  the  mistakes  in  protein  synthesis  might  arise,  one
should  not  forget  about  their  possible  consequence:  the microheterogeneity
of proteins  (122).  To what extent molecules of identical amino acid sequence,
comprising  the bulk of a particular  protein,  are contaminated with molecules
similar to them, but not identical with them, is not quite clear at the moment,
but it is  likely that this contamination  in general  is below  the level of detec-
tion of the routinely used  methods in protein chemistry.  On the other hand,
the  case  of tryptophan  synthetase  in  the  missense  suppressor-containing  E.
coli strain,  in which  90%  of the molecules  of this  enzyme differed  from  10%
of the  molecules by one amino  acid  is certainly  not isolated  (85,  123).
In  conclusion  it  seems  that  we  are  not  far  from  having  completely  de-
ciphered  the  genetic code,  namely,  the one used in mRNA  to specify  amino
acids.  The  problem  of what  might  be  called  the second  genetic  code;  i.e.,
the  signals  by  which  aminoacyl-tRNA  synthetases  recognize  their  specific
tRNA has  been  hardly  touched.  The time  is  ripe  to  attack  this question.
ABBREVIATIONS
The capital letters  A, U,  C,  G, and I  are  used for the residues  of  adenylic,  uridylic,
cytidylic, guanylic, and inosinic acids in oligo- or polynucleotide  chains. AMP,  adeno-
sine-5'-monophosphate;  ATP, adenosine-5'-triphosphate;  GDP,  guanosine-5'-diphos-
phate; GTP,  guanosine-5'-triphosphate;  PP, inorganic pyrophosphate;  DNA, deoxy-,
ribonucleic  acid; RNA,  ribonucleic  acid; mRNA,  messenger RNA;  tRNA,  transfer
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RNA;  poly AC (5: 1)  stands for the random copolymer  consisting of 5 parts  of ade-
nylate residues and 1 part of cytidylate residue; poly AC (1:5), for  the random copoly-
mer consisting of 1 part of adenylate  and 5 parts of cytidylate  residues; poly UG, for
the random copolymer  consisting of uridylate  and  guanylate  residues;  poly (UC)n,
for  a  copolymer  with a repeating  sequence  of UC;  poly  (AAG).,  for  a copolymer
with a repeating  sequence  of AAG.
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Discussion
Dr. Luria: Dr.  Lengyel,  you  told  us  many  wonderful  things  in  this  extremely
illuminating  summary, bringing together the  most modern approaches.
It is no great task to read off coded molecules.  Whatever the details of DNA replica-
tion,  whether  viral  RNA  is  copied  with  the  intermediate  of  a  minus strain  or  not,
however  protein  is  read  off RNA-it is  clear  that  all  these  processes  belong  to  the
same kind of topological approach.  That is,  once  you have a linear  code, you use it,
and  you make the best you can of it. But one of the things that must have happened
in evolution  is that all  these  macromolecules  must  at some point  have  decided that
they had better make a cell or perish. This has really been a very major step. In order
to  make  a  cell  you  need  more  than  macromolecules  with  coded  information.  You
must also have a selective continuity.  By this I mean  that once you have done some-
thing  that works,  you have  to continue  to  do it even  though the  whole information
for doing is not written anywhere.
In the same way that biologic evolution is separate from cultural evolution,  I think
that  template-reading  in evolution  is  separate  from  the  steps in evolution  that must
have  taken place when  these coded macromolecules  had to learn to  make things  for
which they did not have all the knowledge  written inside themselves. Typical of these
are  the  two things  we're going  to be talking  about  this afternoon.  First, how do you
make a complex  polysaccharide  in which you have  exact sequences  and  branches  of
repeat units of different types? There is probably nowhere written in the DNA or the
RNA the  formula  for a  polysaccharide.  You  have to try your luck and,  if you have
luck, then you must have a way to learn the trick. You have to have cultural informa-
tion in order to  continue  to make  a  complex product  whose blueprint is  not written
out.
Second,  even if you can make a polysaccharide and, presumably,  other products of
that  level  of complexity,  you then have to  make a cell.  In order to  make a cell,  you
have to put all these things in order.  In order to put the things in order,  you have to
have a layout. You have to pass from the linear information of the macromolecules  to
the 2- and  3-dimensional  specificity  that is  found in the organization  of a  cell.
So the  last  two  papers  of the  symposium  are  deliberately  devoted  to  finding out
how all these wonderful macromolecules have gotten together  in order  to make cells.
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